Fig. 3
a, b are the time of occurrence of adverse events associated with viloxazine and dextroamphetamine, respectively. c, d are the top 50 PTs of viloxazine and dextroamphetamine in the FAERS database sorted by frequency of AEs, respectively.
Fig. 3 | Scientific Reports
